Drug therapy Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

components: antipsychotic drugs? 1

A
  • treat disorders such as Schizophrenia
  • Positive symptoms are believed to be due to the high levels of Dopamine in the brain
  • which can be explained by the neurons that transmit dopamine firing too easily or often leading to overstimulation and symptoms such as hallucinations, delusions OR there are abnormally high numbers of D2 receptors on receiving neurons . this means more dopamine binds and more neurons fire
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are positive symptoms?

A

symptoms that are added to you - abnormal behav u gain due to to having Sz e.g. hallucinations/ delusions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are negative symptoms?

A

things the person loses - e.g. Sz patients lose emotions/ feelings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

components: antipsychotic drugs? 2

A
  • stay on them forever
  • called dopamine antagonists
  • oldest type = conventional/ typical antipsychotics - CHEAPER e.g. Chlorpromazine
  • bind to D2 receptors to block action = decrease levels of dopamine active in the brain
  • Newer (2nd gen) Atypical antipsychotics e.g. Clozapine
  • temporarily bind to Dopamine receptors then quickly disconnect = fewer side effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is an antagonist drug?

A

type of drug which block/ inhibits the action of neurotransmitters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is an agonist drug?

A

drug which stimulates/ increases the activity of a neurotransmitter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what happens if dopamine levels become too low?

A
  • can happen

- - side effects - no pleasure, less movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

extra: where are D2 receptors found?

A

area of brain called nucleus accumbens, which is a part of the mesolimbic pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

component 2: antidepressant drugs?

A
    • treat mood disorders such as depression
  • symptoms such as sleep problems, low mood, and disruption to appetite are linked to the function of serotonin
  • DEPRESSION = LOW LEVELS OF SEROTONIN e,g, Prozac
  • drugs: Selective Serotonin Re-uptake Inhibitors
    • block the serotonin reuptake channels of the sending neuron
  • increase the amount of serotonin in the synapse available to stimulate the receiving neuron
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are low levels of serotonin caused by?

A
  • the rapid uptake of the chemical or it being broken down by enzymes b4 enough has been passed on from one neuron to the next
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

components: antianxiety drugs? (1 - symptoms)

A
  • symptoms of anxiety include feelings of panic, fearthis may lead to physical symptoms such as a racing heart, palpitations, shortness of breath
  • these are caused by the body’s fight/ flight response to stress/anxiety - increased anxiety levels and activity in the CNS
  • drugs used to treat anxiety help to reduce these physical symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

components: antianxiety drugs? 2

A

1 - Beta Blockers - ANTAGONIST - target the ‘fight or flight stress response
- bind to adrenaline receptor sites on the heart, to prevent the action of adrenaline
- helps to alleviate anxiety symptoms (e.g. racing heart)
2- Benzodiazepines: AGONIST - increases levels of body’s natural anxiety relief ‘GABA’.
- This neurotransmitter reduces activity in our CNS therefore making us feel calmer
- The BZ drug increases how accessible the GABA receptor is

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how biological approach is applied to DT? NEUROTRANSMITTERS

A
  • changes in the brains neurotransmitter systems will affect our mood, emotions, behaviour
  • suggests an alteration or imbalance in the levels of certain brain chemicals may have an impact on ‘normal’ function
  • e.g. assumed that depression is caused by low levels of the neurotransmitter serotonin
  • in relation to the therapy, means by altering function/ levels of certain chemicals w the use of psychotherapeutic drugs, can treat symptoms of certain psychological disorders
  • in general, drug therapy works by blocking the action or increasing the action of diff neurotransmitters in the brain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how biological approach is applied to DT? LOCALISATION OF BRAIN FUNCTION

A
  • refers to the structure & function of diff brain areas and the impact these have on our mood & behaviour
  • e.g. an area in brain known as the limbic system is responsible for regulating our emotions - meaning any disturbances or abnormality in the function of this brain area may affect mood ect
  • this is applicable to the function drug therapy as certain drugs target neurons in certain areas of the brain - improving symptoms of localised in the functions of those areas
  • e.g. an area of the brain called mesolimbic pathway contains D2 receptors that are thought to play a role in + symptoms of Sz - antipsychotic drugs work by targeting the action of these neurons in this localised brain area in order to reduce symptoms of Sz
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how biological approach is applied to DT? THE MEDICA L MODEL

A
  • the BA approach therapy is based on the medical model - which assumes all behavs have a bio basis
  • this is bc the BA assumes behav and mental illness are caused by physiological factors
  • the assumptions of the BA apply the view that mental illnesses should be treat in the same way as physical ones, that their physical symptoms can be dealt w through physiological treatments
  • patients suffering from psy disorders like depress, sz csn be treated through the direct manipulation of their biological bodily processes e.g. thru altering biochemistry levels with drug therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Evaluating the effectiveness of DT: antipsychotics

POINT

A

research supports the evidence of antipsychotics in treating Sz

17
Q

Evaluating the effectiveness of DT: antipsychotics

EVIDENCE

A

Cole et al found 75% of patients given a conventional antipsychotic were ‘much’ improved compared w only 25% of those given a placebo. In addition, none of the patients given the antipsychotic got any worse, compared to 48% of those in the placebo condition

18
Q

Evaluating the effectiveness of DT: antipsychotics

EXPLAIN

A

this shows that the active chemicals in the antipsychotic do have a beneficial effect. it is not simply the thought that you are getting help that works. Furthermore, the cole et al study was published in 1964 and was one of the first to demonstrate that Sz can be treated through the use of drugs. this meant that people with Sz may not need to b restrained in an institution and may be able to live independently in the community as long as drugs were controlling their symptoms

19
Q

Evaluating the effectiveness of DT: antidepressants

POINT

A

research supports the effectiveness of antidepressants in treating major depressive disorder

20
Q

Evaluating the effectiveness of DT: antidepressants

EVIDENCE

A

Cipriani et al (2018) conducted a meta analysis of research carried out into the 22nd gen antidepressants approved in the USA, Europe, Japan. The studies they reviewed had either tested the antidepressant against a placebo, or trialled 2 antidepressants against each other. in all cases the actual drugs were more effective than the placebo

21
Q

Evaluating the effectiveness of DT: antidepressants

EXPLAIN

A

this provides strong evidence that the action of antidepressants in increasing serotonin levels does have a + effect on treating depresion in adults. this study is up to date and builds on earlier research

22
Q

Evaluating the effectiveness of DT: placebos

POINT

A

some studies suggest that placebos mah work as effectively for treating depression

23
Q

Evaluating the effectiveness of DT: placebos

EVIDENCE

A

Kirsch et al (2008) reviewed clinical trials of SSRIs and concluded that only in cases of the most seevre depression was there any sig + of using SSRIs. Moderately depress ppl showed the same improvement when given either the placebo or the drug treatment

24
Q

Evaluating the effectiveness of DT: placebos

EXPLAIN

A

suggests, considering the risk of side effects assoc w antidepressants, they may only be justifiable to use tthem in the most serious cases. Ppl w moderate deprss may be able to make improvements without the need for drug therapy

25
Q

evaluating the ethical issues of DT: placebos

POINT

A

placebos are commonly used when researching effec of DT. This creates an ethical dilemma as they are being denied the potential benefits of the real drug

26
Q

evaluating the ethical issues of DT: placebos

EVIDENCE

A

Khan & Khan (2000) claimed that patients put in the placebo condition are at increased risk of suicide or attempted suicide compared to those in the real drug group

27
Q

evaluating the ethical issues of DT: placebos

EXPLAIN

A

a key ethical principle of conducting research in psy is that no patient should be given treatment known to be inferior. the use of placebos clearly violates this principle & exposes the patients to extreme risk of harm

28
Q

evaluating the ethical issues of DT: side effects

POINT

A

drugs used to treat metal illness cause a range of unpleasant side effects

29
Q

evaluating the ethical issues of DT: side effects

EVIDENCE

A

Antipsychotic drugs cause a range of unpleasant side effects ranging from headaches & nausea to more serious long term effects like weight gain (which may lead to other health issues over time More srsly, can cause plsms w uncontrollable facial moevments known as tardive dyskinesia which affecrs around 70% of patients (in approx 28% this is irreversible)
- life threatening symptoms such as agranulocytosis

30
Q

evaluating the ethical issues of DT: side effects

EXPLAIN

A

this is an issue as DT thfr involves providing patients w a long term form of treatment that may cause them physical harm which may lead to long term health issues

31
Q

evaluating the ethical issues of DT: chemical straightjacket

POINT

A

some ppl view antipsychotics as a chemical straightjacket

32
Q

evaluating the ethical issues of DT: chemical straightjacket

EVIDENCE

A

the antipsychiatry movement claims that antipsychotics are simply a way of keeping ppl quiet and under control. Psychiatrist thomas Szasz went as far as to suggest that the concept of mental illness is simply a way of excluding non conformists from society

33
Q

evaluating the ethical issues of DT: chemical straightjacket

EXPLAIN

A

this P.O.V presents an ethical dilemma abt whether antipsychotics are a genuine way of helping mentall ill ppl from harming themselves and others, or whether drugs are used to make those who society views as ‘abnormal’ tow the line

34
Q

evaluating the ethical issues of CBT: minimising symptoms

POINT

A

DT is ethical bc it’s effec in minimising serious symptoms of mental illness

35
Q

evaluating the ethical issues of CBT: minimising symptoms

EVIDENCE

A

Cole et al (1974) found 75% improvement in patients w Sz as a result of taking antipsychotics. Cipriani et al (2018) found antidepressants are more effec that placebos in treating symptoms of depression

36
Q

evaluating the ethical issues of CBT: minimising symptoms

EXPLAIN

A

this suggests that regardless of some of the ethical issues involved in treating mental illness w DT the fact that they effec in minimising patients’ symptoms of mental illness and allowing them to function more normally within society means they are ethical